The pharmaceutical O2O many platforms but the service quality is uneven in quality still an antidot

Abstract: users usually can not distinguish the nature of the drug, the drug needs deep in the hope that guide the use of professional pharmacists on different types of drugs, drug, medicine O2O products should be provided to the user segments of the service, to meet the different needs of users.

 

The value of pharmacists is particularly important in

‘s daily light care

this year since the "Internet plus" concept, internet medical and pharmaceutical O2O is very influential, hot market, O2O pharmaceutical products have more than 200 users, the product surface is the demand for drugs, but it is essentially a demand for medical services.

drugs have special attributes (symptomatic medication), dual (drug and toxicity), time limit (timely treatment) and so on. The user can not distinguish the nature of the drug, the drug needs deep in the hope that guide the use of professional pharmacists on different types of drugs, drug, medicine O2O products should be provided to the user segments of the service, to meet the different needs of users.

medicine O2O user demand characteristics

prescription drug

China pharmaceutical circulation in the total size of 1 trillion and 300 billion yuan last year, of which the prescription drugs are in the majority of users of prescription drugs for chronic disease patients. Prescription drugs require long-term, sustained use, so users use pharmaceutical O2O products:

is the first to consider the price, high medical costs of chronic diseases bring heavy burden to the families of patients, as long as a box of drug prices cheaper every year can save a lot of cost;

is the second consideration payment, if the pharmaceutical O2O products can solve the problem of medical insurance payment, so each user can save large expenses;

Finally,

is chronic disease management, patients with chronic diseases due to various reasons lead to forget to take, seriously affect the treatment effect, only to establish a reasonable mode of chronic disease management to help patients to complete the treatment, bring real product value to the user, in order to improve user stickiness of the product.

OTC

last year, China’s total OTC sales of nearly 300 billion, although the market share is lower than prescription drugs, but the total demand is still very alarming. Users of OTC drugs are a different kind of demand:

is the first treatment effect, when consumers are sick, usually based on their own life experience and common sense to buy drugs, drugs can be symptomatic treatment, which is the core of the pharmaceutical O2O products to solve the problem;

is followed by the use of drugs, the vast majority of consumers are lack of professional knowledge of drug use, when the user to get the drug, the use of drugs is correct, should be provided by a professional pharmacist services;

is the last time, according to the survey, the pharmaceutical O2O products purchased by the user >

Leave a Reply

Your email address will not be published. Required fields are marked *